T-Cell Lymphoma Forum

Secura Bio, Inc. is an integrated, commercial-stage pharmaceutical company dedicated to the worldwide development and commercialization of impactful oncology therapies for physicians and their patients. Secura Bio was established in 2019 with a singular mission: to close the gap between innovative oncology therapies and the patients who need them most. For more information on Secura Bio, please visit www.securabio.com

Platinum Sponsors

Citius Oncology (NASDAQ: CTOR) is a start up biopharmaceutical company focused on commercializing innovative targeted oncology therapies. The company has launched LYMPHIR™ (denileukin diftitox-cxdl), for patients with stage 1-3, relapsed or refractory cutaneous T-cell lymphoma (CTCL) in the US. Please contact us if you have any questions or visit www.lymphir.com

The UVA Comprehensive Cancer Center is one of just 57 in the nation to hold that designation by the National Cancer Institute, and the first in Virginia. Our more than 250 researchers pursue discovery in support of cancer prevention, detection and treatment. UVACCC’s work directly supports patients seen by UVA Health clinicians and individuals who live in the UVACCC catchment area through outreach partnerships. UVACCC offers robust education and career development activities to participants ranging from elementary school students to junior faculty to train the next generation of cancer researchers and clinicians. UVACCC strives to reduce the burden of cancer for all. Additionally, affiliated research initiatives pursue discovery related to rare or “orphan” cancers, and novel treatment methods. UVACCC is proud to support the 17th Annual T-cell Lymphoma Forum in San Diego.

Gold Sponsors

Celltrion is a global biopharmaceutical leader dedicated to enhancing patient well-being.
As the pioneer that launched the world’s first monoclonal antibody biosimilar, we boast an annual production capacity of 250,000L, making us Korea’s largest manufacturer and exporter in the sector. For over two decades, we have expanded treatment accessibility through advanced, affordable healthcare solutions. Moving forward, we are elevating our impact by diversifying our portfolio into innovative new drugs, including multi-specific antibodies and antibody-drug conjugates (ADCs), to create a healthier future for everyone.

Kyowa Kirin is a Japan-based global specialty pharmaceutical company focused on next generation antibodies and cell and gene therapies to help patients diagnosed with bone and mineral, intractable hematological diseases/hemato oncology, and rare diseases. We have a shared commitment to our values and Kabegoe principles, to sustainable growth, and to translating science into smile across the globe. www.kkna.kyowakirin.com.

Silver Sponsors

Therakos LLC specializes in photopheresis technology and has the only FDA approved extracorporeal photopheresis treatment in the US. Please see full Prescribing Information, including the BOXED WARNING for UVADEX (methoxsalen) Sterile Solution at www.therakos.com/pi and see the THERAKOS Photopheresis System Operator’s Manual. To learn more about our product visit www.therakos.com

GC Cell stands at the forefront of cell therapy innovation with fully-integrated capability from research to commercialization. Offering customized solutions tailored to partners’ needs, We provide end-to-end full value chain CDMO and bio logistics service. Our mission is to fast-track the innovation in cell and gene therapies, aiming to enhance the clinical outcomes of each and every patient, shaping the future of healthcare.

Nouveau Biosciences brings together leaders in business, science, and regulation to advance oncology drug discovery and development. We pioneer technologies enabling rapid creation of targeted cancer therapies. With a clinic-ready lead asset and scalable, IP-protected platform, we generate de-risked drug candidates with strong potential for swift market entry to patients.

Diamond Sponsor

Platinum Sponsors

Gold Sponsors

Silver Sponsors

Bronze Sponsors